State of the Art - Optimizing the prevention of venous thromboembolism

27 August 2018 (16:45 - 17:03)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Alex Spyropoulos

Northwell Health, New York (United States of America)

3 More presentations in this session

Presentation thumbnail

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Doctor Y. Yamashita (Kyoto, JP)

Abstract Slides Video

Presentation thumbnail

Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

Doctor E. Klok (Leiden, NL)

Presentation thumbnail

Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial

Doctor A. KALAYCI (Boston, US)

Abstract Slides Video

Access the full session

Session thumbnail

Progress in anticoagulation for venous thromboembolism

The Event

ESC Congress 2018

27 August 2018 16:45 CET

You may be interested in

Congress Session

From bench to bedside: how changes in the data landscape have shaped venous thromboembolism treatment as well as prevention of recurrence

26 August 2023

Congress Presentation

Statins for venous thromboembolism prevention: old dog, new tricks

1 September 2020

Webinar

How to Improve Implementation of Prevention Guidelines: Barriers, Tips and Tricks

9 December 2019

Congress Presentation

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.

31 August 2019

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources